On September 10, 2025, a groundbreaking study was released that explores a novel approach to spinal cord repair. The research centers around inhibiting an astrocytic 'brake' mechanism that, until now, has hindered neuronal regeneration post-injury. This study is significant as spinal cord injuries often lead to permanent loss of motor and sensory functions, largely due to the complex nature of the injury response.

The Molecular Brake Mechanism

Led by Director C. Justin Lee from the Institute for Basic Science, the research team collaborated with Professor Ha Yoon from Yonsei University College of Medicine to unveil the role of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), produced by astrocytes through the enzyme monoamine oxidase B (MAOB). They showed that GABA serves as a key inhibitory factor blocking recovery after spinal cord injury.

Key Findings

The study, published in Signal Transduction and Targeted Therapy, presents several pivotal findings:

  • The overexpression of MAOB in astrocytes was identified as a critical factor suppressing neuronal recovery.
  • Inhibition of MAOB, through the administration of KDS2010, facilitated neuronal preservation and promoted myelination at the injury site.
  • Functional recovery was observed, with treated mice showing significant improvements in locomotion and reduced lesion cavities as evidenced through various tests.

Impact of GABA and MAOB

The research outlines how excessive GABA production inhibits neuronal growth signals by suppressing the expression of brain-derived neurotrophic factor (BDNF) and its receptor TrkB, both crucial for neuronal regeneration. The resulting molecular brake curtails the axonal regrowth essential for recovery.

Mechanism Impact on Neuronal Repair
Inhibition via GABA Blocks expression of BDNF and TrkB; inhibits axonal regrowth.
MAOB Overexpression Prevents neuronal repair and results in functional loss.
MAOB Inhibition (KDS2010) Restores neuronal growth signals; promotes functional recovery.

Experimental Validation

The team employed an animal model approach, manipulating MAOB expression to gauge its effects. Their findings exhibited a direct correlation between MAOB activity and neuronal regeneration:

  1. Inhibition of MAOB led to axonal regrowth and recovery of motor functions.
  2. Enhanced MAOB expression resulted in severe tissue loss and diminished functional recovery.

Future Prospects and Clinical Trials

Looking ahead, the researchers plan to advance KDS2010 into Phase II clinical trials to assess its effectiveness in spinal cord injury patients. This represents a shift from existing therapies that primarily focus on symptom management to addressing the root causes of regeneration inhibition.

“This study identifies a direct molecular pathway that suppresses neural regeneration after spinal cord injury and presents a strategy to overcome it. Unlike existing treatments, this offers a fundamentally new therapeutic approach.” – Dr. C. Justin Lee

Broadening Horizons

Moreover, the implications of this research are not limited to spinal cord injuries. The team intends to explore the significance of the MAOB-GABA pathway in other neurological disorders, potentially laying the foundation for a comprehensive therapeutic platform.

Conclusion

In conclusion, the study's findings emphasize the importance of targeting the MAOB-GABA pathway to foster neuronal regeneration following spinal cord injuries. This innovative approach could herald a new era of treatments aimed at restoring mobility and function in affected patients.

References

Article Source: Inhibiting an astrocytic 'brake' that blocks spinal cord repair could pave path to neuronal regeneration (2025, September 10) retrieved from Science X.